Opportunity ContactJames Noh, CEOSeoul, South Korea Hanyang University Website Pharmalicensing.com A research team from Hanyang University in South Korea has developed a new technology for discovering therapeutic target genes for individual cancer patients with
Opportunity ContactJames Noh, CEOSeoul, South Korea Oncobix Oncology Biosciences Website Pharmalicensing.com Mutation in the kinase region of the epidermal growth factor receptor (EGFR) is found in some non-small cell lung cancer patients
Opportunity ContactMark Treharne, Head of Corporate DevelopmentLondon, United Kingdom ValiRx Website Pharmalicensing.com VAL401 is the reformulation of the anti-psychotic drug Risperidone in a lipid-based capsule which enables anti-cancer biology that is not
ur client is currently developing a new functionalized silica nanoparticle as a drug delivery vector for nucleic acid payloads.
Our client is a pharmaceutical company seeking US FDA and/or EMA approved Prescription (Rx) Drugs and Medical Foods for the Swiss market in Oncology, Hematology, Infectious Disease, Hepatology, Gastrology, Transplant, Hematology, and Hepatology.
Scouting Pharmaceuticals For Commercialization In Russia/CIS And Global Named Patient Programs (NPPs)